Endometriosis Pelvic Pain (DREAMLAND Trial)

When “Fixed” Still Hurts

How a CBD‑enriched oil was tested for stubborn pelvic pain after endometriosis surgery.

If you’ve had surgery for endometriosis and still live with pelvic pain, you know the strange mix of relief and disappointment. On paper, things are “better,” but your day is still organized around what your body will or won’t let you do.

It’s no surprise, then, that many women start looking beyond the usual options. One of the most talked‑about ideas right now is CBD‑enriched oil as an add‑on for chronic pelvic pain—and the DREAMLAND clinical trial is one of the first to put that idea to the test in a structured way.

What did this trial actually do?

The DREAMLAND study (full formal title shortened here) was designed to see whether an oral CBD‑enriched extract could help women living with persistent pelvic pain after surgery for endometriosis. Instead of relying on anecdotes, the researchers used a randomized clinical trial format.

In plain language, here’s what they did:

• Enrolled women with chronic pelvic pain following surgically treated endometriosis.
• Randomized participants to receive CBD‑enriched oil or a comparator, on top of whatever standard care they were already receiving.
• Followed them for a defined period, measuring:
  • Pain intensity scores
  • Impact on daily activities and quality of life
  • Side effects and overall tolerability

The goal wasn’t to “prove CBD cures endometriosis.” The goal was to see whether adding a CBD‑rich extract could meaningfully shift pain and function in a group of women who had already been through a lot.

What did they find?

The authors reported that women taking the CBD‑enriched extract experienced reductions in pelvic pain that were clinically meaningful for many participants, compared with controls. Improvements showed up not only in numeric pain scores, but also in several measures of how much pain was interfering with daily life.

Key points from the results:

• Pain levels: Many women in the CBD group saw a drop in pain intensity versus their baseline and versus the comparator group.
• Function: Some participants reported better ability to manage normal activities and felt less “ruled” by their pain.
• Tolerability: Overall, the CBD‑enriched oil was considered acceptable in terms of side effects over the trial duration, though some people did report issues like fatigue or GI symptoms.

The authors were careful to say that this is early evidence, not a final verdict. The trial was not designed to show long‑term outcomes over years, nor did it test every possible dose or formulation of CBD.

How might CBD help pelvic pain?

Endometriosis‑related pelvic pain appears to involve a mix of factors: persistent inflammation, nerve sensitization, muscle spasm, and central pain processing changes. CBD, a non‑intoxicating cannabinoid, has been studied for potential anti‑inflammatory, analgesic, and muscle‑relaxant properties in various models.

In theory, CBD might support pelvic pain relief by:

• Modulating inflammatory signaling that contributes to ongoing pain
• Influencing neurotransmitter systems involved in how pain signals are processed
• Helping relax overactive muscles contributing to cramping and deep pelvic ache

This trial doesn’t prove those mechanisms in humans; it simply shows that, in this particular setting, a CBD‑enriched oil was associated with better pain and function outcomes than a comparison treatment.

What this means for you

The problem: even after “successful” endometriosis surgery, many women still face chronic pelvic pain, often with limited options that feel sustainable or acceptable long term.

Here’s how to interpret this study in practical terms:

• CBD‑enriched oil is being studied as an add‑on, not a replacement. In DREAMLAND, CBD was layered on top of existing care, not used instead of hormonal therapy, surgery, or other pain strategies.
• Response is individual. Some women in the CBD group reported meaningful relief, while others saw more modest changes. There is no guarantee that CBD will work the same way for everyone.
• Safety and interactions matter. CBD can affect liver enzymes and interact with other medications, especially when taken orally at higher doses. That’s particularly important if you’re on hormones, antidepressants, anticonvulsants, or other chronic meds.

Instead of thinking “CBD is the answer,” it’s more realistic to think “CBD might be one more tool we test thoughtfully, with a plan and clinical guidance.”

A safer way to experiment

If this trial has you curious, here’s a more structured way to approach it, inspired by how the study was run:

• Talk to your gynecologist or pain specialist first. Share that you’re interested in CBD and mention that there is a clinical trial (like DREAMLAND) exploring it as an add‑on for post‑surgical pelvic pain.
• Pick a defined trial period. For example, agree to try a specific, reputable CBD product for 4–8 weeks, with a clear starting dose and schedule.
• Track a few simple measures. Pain score (0–10), activity limits, sleep quality, and any side effects. That gives you and your clinician something tangible to evaluate.
• Decide in advance what “success” looks like. For instance, a 2‑point drop in average pain, or being able to do certain daily tasks more easily.

That kind of plan doesn’t guarantee CBD will help—but it does help you avoid random, frustrating trial‑and‑error.

---

About the Original Study

Title: Cannabidiol-Enriched Extract Oil for Postoperative Management of Chronic Pelvic Pain Secondary to Endometriosis: A Randomized Clinical Trial—DREAMLAND Study

Year: 2026 (published online January 2026)

Journal: Women’s Health (SAGE Journals)

Journal article: https://journals.sagepub.com/doi/10.1177/25785125251413989

Clinical trial registration:
ClinicalTrials.gov – NCT05670353
https://clinicaltrials.gov/study/NCT05670353

Authors:

Based on the Semantic Scholar listing and trial registry, the lead/corresponding authors are:

• Thais Anelli (Lead investigator) – Gynecology and reproductive health researcher, Brazil. (Individual profile not yet available; full author affiliations listed on journal page: https://journals.sagepub.com/doi/10.1177/25785125251413989)
• Natalia Ratochinski (Co-author) – Endometriosis clinical research, Brazil. (Full author affiliations on journal page.)
• Full investigator and author list with institutional affiliations:
  https://journals.sagepub.com/doi/10.1177/25785125251413989

Trial sponsor overview:
https://ctv.veeva.com/study/cannabidiol-for-the-treatment-of-pelvic-pain-in-endometriosis-dreamland

---